Rajpar, S <br/><br/>
Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Sep 2010 
 - 1864-1869 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdq037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--urine<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Neoplasms--mortality<br/>Castration<br/>Collagen Type I--urine<br/>Diphosphonates--therapeutic use<br/>Follow-Up Studies<br/>Humans<br/>Imidazoles--therapeutic use<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Neoplasms, Hormone-Dependent--mortality<br/>Peptides--urine<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--mortality<br/>Survival Rate<br/>Treatment Outcome<br/>Zoledronic Acid